FSPCX
Price
$89.17
Change
+$0.63 (+0.71%)
Updated
Oct 17 closing price
Net Assets
872.44M
RYFCX
Price
$73.75
Change
+$0.57 (+0.78%)
Updated
Oct 17 closing price
Net Assets
11.79M
Interact to see
Advertisement

FSPCX vs RYFCX

Header iconFSPCX vs RYFCX Comparison
Open Charts FSPCX vs RYFCXBanner chart's image
Fidelity Select Insurance Port
Price$89.17
Change+$0.63 (+0.71%)
VolumeN/A
Net Assets872.44M
Rydex Financial Services C
Price$73.75
Change+$0.57 (+0.78%)
VolumeN/A
Net Assets11.79M
FSPCX vs RYFCX Comparison Chart in %
View a ticker or compare two or three
VS
FSPCX vs. RYFCX commentary
Oct 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPCX is a Buy and RYFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPCX has more cash in the bank: 872M vs. RYFCX (11.8M). FSPCX pays higher dividends than RYFCX: FSPCX (1.03) vs RYFCX (0.96). FSPCX was incepted earlier than RYFCX: FSPCX (40 years) vs RYFCX (25 years). RYFCX (2.44) is less costly to investors than FSPCX (0.69). RYFCX is a more actively managed with annual turnover of: 280.00 vs. FSPCX (55.00). FSPCX has a lower initial minimum investment than RYFCX: FSPCX (0) vs RYFCX (2500). RYFCX annual gain was more profitable for investors over the last year : 6.20 vs. FSPCX (-9.44). FSPCX return over 5 years is better than : 77.38 vs. RYFCX (41.25).
FSPCXRYFCXFSPCX / RYFCX
Total Expense Ratio0.692.3929%
Annual Report Gross Expense Ratio0.692.4428%
Fund Existence40 years25 years-
Gain YTD-1.0476.560-16%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets872M11.8M7,390%
Annual Yield % from dividends1.030.96107%
Returns for 1 year-9.446.20-152%
Returns for 3 years34.8516.91206%
Returns for 5 years77.3841.25188%
Returns for 10 years37.2563.5559%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESPR2.750.10
+3.77%
Esperion Therapeutics
WSFS51.340.99
+1.97%
WSFS Financial Corp
CDW152.451.35
+0.89%
CDW Corp
EUDA3.32-0.10
-2.92%
EUDA Health Holdings Limited
MHUA0.33-0.03
-8.88%
Meihua International Medical Technologies Co Ltd